Close Window

Digital Look Email A Friend

AstraZeneca 'disappointed' with FDA panel vote on prostate drug

Published by Frank Prenesti on 2nd May 2023

(Sharecast News) - AstraZeneca said it was disappointed with a decision by a panel of US Food and Drug Administration advisers to restrict use of its treatment for a type of prostate cancer.

URL: http://www.digitallook.com/dl/news/story/33473436/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.